Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Barton

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Plos One|January 6, 2021
Differentiating axonal loss and demyelination in chronic MS lesions: A novel approach using single streamline diffusivity analysisSamuel Klistorner, Michael H Barnett, Jakob Wasserthal, et al.
Multiple Sclerosis and Related Disorders|May 18, 2020
Precision therapy for neuromyelitis optica spectrum disorder: A retrospective analysis of the use of class-switched memory B-cells for individualised rituximab dosing schedulesBenjamin P Trewin, Stephen Adelstein, Judith M Spies, et al.
Neuroimage. Clinical|February 2, 2018
Evidence of progressive tissue loss in the core of chronic MS lesions: A longitudinal DTI studyAlexander Klistorner, Chenyu Wang, Con Yiannikas, et al.
Multiple Sclerosis and Related Disorders|July 31, 2019
Investigation of tumefactive demyelination is associated with higher economic burden and more adverse events compared with conventional multiple sclerosisMatthew Silsby, Pedro Sánchez, Judith M Spies, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 30, 2021
Multiple sclerosis: structural and functional integrity of the visual system following alemtuzumab therapyChenyu Wang, Joshua Barton, Kain Kyle, et al.
Archives of Surgery (Chicago, Ill. : 1960)|February 17, 2010
Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survivalJavairiah Fatima, Thomas Schnelldorfer, Joshua Barton, et al.
Vaccines|August 29, 2024
Development and Application of Automated Sandwich ELISA for Quantitating Residual dsRNA in mRNA VaccinesDavid A Holland, Jillian Acevedo-Skrip, Joshua Barton, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 21, 2017
Progressive inner nuclear layer dysfunction in non-optic neuritis eyes in MSYuyi You, Elizabeth C Graham, Ting Shen, et al.
Ophthalmology|February 4, 2019
Evidence of Müller Glial Dysfunction in Patients with Aquaporin-4 Immunoglobulin G-Positive Neuromyelitis Optica Spectrum DisorderYuyi You, Ling Zhu, Ting Zhang, et al.
Journal for Immunotherapy of Cancer|August 22, 2020
Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunityJohn C Flickinger, Jagmohan Singh, Robert Carlson, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Plos One|January 6, 2021
Differentiating axonal loss and demyelination in chronic MS lesions: A novel approach using single streamline diffusivity analysisSamuel Klistorner, Michael H Barnett, Jakob Wasserthal, et al.
Multiple Sclerosis and Related Disorders|May 18, 2020
Precision therapy for neuromyelitis optica spectrum disorder: A retrospective analysis of the use of class-switched memory B-cells for individualised rituximab dosing schedulesBenjamin P Trewin, Stephen Adelstein, Judith M Spies, et al.
Neuroimage. Clinical|February 2, 2018
Evidence of progressive tissue loss in the core of chronic MS lesions: A longitudinal DTI studyAlexander Klistorner, Chenyu Wang, Con Yiannikas, et al.
Multiple Sclerosis and Related Disorders|July 31, 2019
Investigation of tumefactive demyelination is associated with higher economic burden and more adverse events compared with conventional multiple sclerosisMatthew Silsby, Pedro Sánchez, Judith M Spies, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 30, 2021
Multiple sclerosis: structural and functional integrity of the visual system following alemtuzumab therapyChenyu Wang, Joshua Barton, Kain Kyle, et al.
Archives of Surgery (Chicago, Ill. : 1960)|February 17, 2010
Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survivalJavairiah Fatima, Thomas Schnelldorfer, Joshua Barton, et al.
Vaccines|August 29, 2024
Development and Application of Automated Sandwich ELISA for Quantitating Residual dsRNA in mRNA VaccinesDavid A Holland, Jillian Acevedo-Skrip, Joshua Barton, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 21, 2017
Progressive inner nuclear layer dysfunction in non-optic neuritis eyes in MSYuyi You, Elizabeth C Graham, Ting Shen, et al.
Ophthalmology|February 4, 2019
Evidence of Müller Glial Dysfunction in Patients with Aquaporin-4 Immunoglobulin G-Positive Neuromyelitis Optica Spectrum DisorderYuyi You, Ling Zhu, Ting Zhang, et al.
Journal for Immunotherapy of Cancer|August 22, 2020
Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunityJohn C Flickinger, Jagmohan Singh, Robert Carlson, et al.
Pageof 3